Clinical Trial Update: microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin

View source ↗

Summary

An update on a HER2-positive breast cancer patient treated with Herceptin (trastuzumab), focusing on microRNA findings related to the case.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Breast Cancer | Status: UNKNOWN